| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |